SHFSNasdaq grants Safe Harbor Financial extra 180 days to meet bid priceOct 21INDPIndaptus Therapeutics completes $24 million private placementOct 21JEFJefferies discloses recent share repurchases at investor meetingOct 20LNZALanzaTech Global Files 8-K for LanzaJet Recapitalization and $10M Note IssuanceOct 20SJTSan Juan Basin Royalty Trust skips October distribution due to cost deficitOct 20EARNINGSAmy Schumer posts Caribbean vacation photos after weight-loss updateOct 20EARNINGSSpaceX Q3 revenue jumps 161% to $14.6 billionOct 20WORLDNew US medium-lift rockets emerge 13 years after Antares debutOct 20NFLXNetflix cites monetization focus amid falling viewing time reportsOct 20EARNINGSOppenheimer Raises S&P 500 2026 EPS Forecast to $365Oct 20SHFSNasdaq grants Safe Harbor Financial extra 180 days to meet bid priceOct 21INDPIndaptus Therapeutics completes $24 million private placementOct 21JEFJefferies discloses recent share repurchases at investor meetingOct 20LNZALanzaTech Global Files 8-K for LanzaJet Recapitalization and $10M Note IssuanceOct 20SJTSan Juan Basin Royalty Trust skips October distribution due to cost deficitOct 20EARNINGSAmy Schumer posts Caribbean vacation photos after weight-loss updateOct 20EARNINGSSpaceX Q3 revenue jumps 161% to $14.6 billionOct 20WORLDNew US medium-lift rockets emerge 13 years after Antares debutOct 20NFLXNetflix cites monetization focus amid falling viewing time reportsOct 20EARNINGSOppenheimer Raises S&P 500 2026 EPS Forecast to $365Oct 20

Pomerantz LLP launches investor investigation into Identiv (INVE)

A securities investigation is now in focus for Identiv, Inc. (NASDAQ: INVE) after Pomerantz LLP disclosed on July 9, 2026, that it is examining claims on behalf of the company's investors. A formal filing from the New York firm would be the next confirmable development.

By Grant HalloranMacro DeskJuly 18, 20262 min read
Share

Key takeaways

  • Pomerantz LLP disclosed on July 9, 2026, that it is investigating claims on behalf of investors in Identiv, Inc. (NASDAQ: INVE).
  • The firm has not identified the nature of the claims, the time period under review, or any financial figures.
  • Pomerantz is asking investors who believe they may have claims to come forward through designated contact Danielle Peyton ([email protected] or 646-581-9980, ext. 7980).
  • No complaint had been confirmed as of the July 9, 2026 disclosure.
  • Investors are watching for a formal filing from Pomerantz or a public statement from Identiv acknowledging the inquiry.

A securities investigation is now in focus for Identiv, Inc. (NASDAQ: INVE) after Pomerantz LLP disclosed on July 9, 2026, that it is examining claims on behalf of the company's investors. A formal filing from the New York firm would be the next confirmable development.

The investigation

Pomerantz has not identified the nature of the claims, the time period under review, or any financial figures in its announcement. The firm is asking investors who believe they may have claims to come forward. Danielle Peyton is the designated contact: [email protected] or 646-581-9980, ext. 7980.

What to watch

No complaint has been confirmed as of the July 9 disclosure. INVE investors are watching for a formal filing from Pomerantz or any public statement from Identiv acknowledging the inquiry. Danielle Peyton at ext. 7980 remains the only named information channel as of the announcement.


Note: The source material contains only the facts reflected above. Per desk policy, this piece runs short rather than padded.

Related reading

About this story

Filed by the macro desk of MarketPR on July 18, 2026. Source: prnewswire.com. Indicative figures are not investment advice.

←Back to the news index

Frequently asked

Who launched the investigation into Identiv?

Pomerantz LLP, a New York law firm, launched the investigation on behalf of Identiv investors, disclosing it on July 9, 2026.

What are the specific claims against Identiv?

Pomerantz has not identified the nature of the claims, the time period under review, or any financial figures in its announcement.

How can investors get involved or find more information?

Investors who believe they may have claims can contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980, the only named information channel as of the announcement.

Has a lawsuit or complaint been filed against Identiv?

No complaint had been confirmed as of the July 9, 2026 disclosure; investors are watching for a formal filing or a public statement from Identiv.